Islet Cell Transplantation ProcedureDescription, Latest Information and Doctors
Learn About Islet Cell Transplantation
Bariatric Surgery Center
Andrew Posselt is a Transplant Surgeon practicing medicine in San Francisco, California. Dr. Posselt is rated as an Elite provider by MediFind in Islet Cell Transplantation. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Obesity, Chronic Pancreatitis, Chronic Antibody-Mediated Rejection, Islet Cell Transplantation, and Sleeve Gastrectomy. Dr. Posselt is board certified in American Board Of Surgery, General Surgery. Dr. Posselt is currently accepting new patients.
University Of Illinois At Chicago
Jose Oberholzer is a Transplant Surgeon practicing medicine in Chicago, Illinois. Dr. Oberholzer is rated as an Elite provider by MediFind in Islet Cell Transplantation. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Liver Failure, Islet Cell Transplantation, and Pancreas Transplant.
City Of Hope Comprehensive Cancer Center-Duarte
Fouad Kandeel is an Endocrinologist practicing medicine in Duarte, California. Dr. Kandeel is rated as an Elite provider by MediFind in Islet Cell Transplantation. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Anaplastic Thyroid Cancer, Islet Cell Transplantation, and Pancreaticoduodenectomy. Dr. Kandeel is currently accepting new patients.
Summary: This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and efficacy of OPF-310 transplantation and to define the recommended Phase 2 dose (RP2D) in adult subjects with unstable Type 1 Diabetes Mellitus (T1DM) and a level 3 (severe) hypoglycemic episode at least three times within the 1...
Summary: Single arm- subject treated with Tegoprubart and everolimus. The purpose of this research is to gather information on the safety and effectiveness of investigational regimen containing 2 experimental components: * An investigational drug called Tegoprubart and * Human pancreatic islet cells Both Tegoprubart and human pancreatic islet cells are considered investigational because they are not approv...